Aller au contenu principal
Profil bibliographique

Walaa A Alshahrani

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

16Publications signalées
43Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementLymphoma Diagnosis and TreatmentCOVID-19 Clinical Research StudiesLipoproteins and Cardiovascular Health

Les publications récentes

Accès ouvert 2026 article OpenAlex

Effectiveness and safety of brentuximab vedotin-containing regimen versus standard chemotherapy in relapsed or refractory Hodgkin lymphoma: a multicenter cohort study

Abdullah M. Alrajhi, Bashayer Alshehri, Walaa A Alshahrani, Arwa Alhaj Issa et autres

Introduction: Hodgkin Lymphoma (HL) accounts for 3.4% of all cancers in Saudi Arabia and poses significant challenges with relapse rates reaching 40% in advanced stages. Brentuximab vedotin (BV), a novel agent targeting CD-30, has shown promise in improving outcomes. This study aims …

sa, gb, fi (code pays fourni par la source)

0 citations Hematology
Accès ouvert 2026 review OpenAlex

Clinical Outcomes with the Use of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Among Patients with Diabetes Mellitus and COVID-19: A Systematic Review of Observational Studies

Shaden A. Alkhalifah, Walaa A Alshahrani, Abdulmajeed M. Alshehri, Majed S. Al Yami

Background: Diabetics with coronavirus disease 2019 (COVID-19) manifest more adverse clinical outcomes with elevated rates of death. It has been suggested that the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pathway of entrance into the host cell might be assisted by dipeptidyl …

sa (code pays fourni par la source)

0 citations Journal of Clinical Medicine
Accès ouvert 2026 review OpenAlex

Reduced Versus Full-Dose Direct Oral Anticoagulants for Long-Term Management of Venous Thromboembolism: A Systematic Review

Manar Al Arifi, Walaa A Alshahrani, Abdulmajeed M. Alshehri, Majed S. Al Yami

Background: Venous thromboembolism (VTE) is still a serious clinical problem because many patients still have a significant chance of having it happen again after their first course of anticoagulation is over. In recent years, reduced-dose direct oral anticoagulants (DOACs) have been investigated …

sa (code pays fourni par la source)

2 citations Journal of Clinical Medicine
Accès ouvert 2026 review OpenAlex

Anemia as a Potent and Underrecognized Driver of Venous Thromboembolism: A Systematic Review

Ghaith K. Mansour, Walaa A Alshahrani, Lama Alfehaid, Abdulmajeed M. Alshehri et autres

Background: Nutritional deficiency anemias—including iron, vitamin B12, and folate deficiencies—are common worldwide and are increasingly recognized as potential contributors to venous thromboembolism (VTE). Mechanistic and epidemiologic data suggest that anemia may promote thrombosis through hypoxia, endothelial activation, reactive thrombocytosis, and hyperhomocysteinemia. However, …

sa (code pays fourni par la source)

4 citations Journal of Clinical Medicine
Accès ouvert 2025 review OpenAlex

Clinical Outcomes Associated with Statin Use in Pulmonary Embolism: A Systematic Review of Observational Studies

Walaa A Alshahrani, Abdulmajeed M. Alshehri, Majed S. Al Yami

Background: Pulmonary embolism (PE) represents one of the most serious complications of venous thromboembolism (VTE). Conflicting studies indicate that statins could play a role in preventing recurrent VTE or improving survival in patients with PE. This review aims to assess the impact …

sa (code pays fourni par la source)

1 citation Journal of Clinical Medicine
Accès ouvert 2025 article OpenAlex

Evaluation of the Clinical Outcomes of Apixaban Use in Patients with Atrial Fibrillation and Uncontrolled Hypothyroidism: A Real-world Evidence

Khalid Al Sulaiman, Manal A Aljohani, Abdullah F. Alharthi, Hisham A. Badreldin et autres

IntroductionAtrial fibrillation (AF) poses a substantial worldwide health concern, significantly increasing the risk of stroke and morbidity. Direct oral anticoagulants (DOACs) such as apixaban are recommended over vitamin K antagonists for the management of AF. However, the impact of thyroid abnormalities on …

sa, us (code pays fourni par la source)

0 citations Clinical and Applied Thrombosis/Hemostasis
Accès ouvert 2025 article OpenAlex

Acceptance of Pulmonary Telerehabilitation Among Healthcare Practitioners

Gayathri Pandurangam, Swathi Gurajala, Laila Almarhoon, Talah Aljaloud et autres

INTRODUCTION: Pulmonary rehabilitation is a clinical approach designed to support individuals with chronic respiratory diseases through structured exercise and educational strategies. Pulmonary telerehabilitation (PTR) represents a remote adaptation of this approach, offering services through virtual platforms. This model may enhance patient engagement …

sa (code pays fourni par la source)

0 citations Cureus
Accès ouvert 2025 article OpenAlex

Clinical features and outcomes of newly diagnosed classical Hodgkin lymphoma patients in Saudi Arabia: a multicenter cohort study

Mai Alalawi, Abdullah M. Alrajhi, Walaa A Alshahrani, Amal H. Alotaibi et autres

Classical Hodgkin Lymphoma (cHL) is a prominent B-cell neoplasm, that impacts global and Saudi populations. Given limited large-scale studies focusing on HL in Saudi Arabia, this retrospective multicenter cohort study reviewed the characteristics and clinical outcomes of patients with cHL in Saudi …

sa, gb (code pays fourni par la source)

2 citations Scientific Reports
Accès ouvert 2025 article OpenAlex

Effectiveness and Safety of Nirmatrelvir-Ritonavir in Hospitalized Patients with COVID-19: A Two-center Cohort Study

Raghad Alhajaji, Manal Z. Alfahmi, Khalid Al Sulaiman, Aisha Alharbi et autres

Abstract Background: On May 25, 2023, the antiviral medication nirmatrelvir-ritonavir received complete FDA authorization, making it the first oral antiviral to treat mild-to-moderate COVID-19 in high-risk patients for progression to severe COVID-19. While the effect of nirmatrelvir-ritonavir is endorsed in non-hospitalized patients, …

sa, us (code pays fourni par la source)

0 citations Saudi Journal of Clinical Pharmacy
Accès ouvert 2024 article OpenAlex

Real-World safety and effectiveness of evolocumab in primary hypercholesterolemia and mixed dyslipidemia in Saudi Arabia

Abdulaali R. Almutairi, Walaa A Alshahrani, Ghaida K Alhathlol, Fatimah Alsheikh et autres

Introduction: Evolocumab's short-term efficacy and safety were proven in phase-3 clinical trial, but its long-term safety and effectiveness in the Saudi population are yet to be studied. The aim of this study was to assess the long-term safety and effectiveness of evolocumab …

sa (code pays fourni par la source)

3 citations Saudi Pharmaceutical Journal
Accès ouvert 2024 article OpenAlex

Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes

Sumaya N. Almohareb, Osamah M. Alfayez, Shoroq S. Aljuaid, Walaa A Alshahrani et autres

Background: GLP-1 receptor agonists (GLP-1RA) are used in the management of type II diabetes mellitus or obesity, although its role in patients with type I diabetes mellitus (T1DM) has been debated. This study aimed to investigate the efficacy and safety of GLP-1RA …

sa (code pays fourni par la source)

19 citations Journal of Clinical Medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.